Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy

Diabetes Care. 2015 Apr;38(4):e55-7. doi: 10.2337/dc14-2349.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged, 80 and over
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Autoimmunity
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / chemically induced*
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / pathology
  • Disease Progression
  • Female
  • Humans
  • Immunotherapy / adverse effects*
  • Male
  • Middle Aged
  • Neoplasms / immunology
  • Neoplasms / therapy
  • Nivolumab
  • Programmed Cell Death 1 Receptor / immunology*

Substances

  • Antibodies, Monoclonal
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Nivolumab